GB9515868D0 - Therapeutic method - Google Patents

Therapeutic method

Info

Publication number
GB9515868D0
GB9515868D0 GBGB9515868.9A GB9515868A GB9515868D0 GB 9515868 D0 GB9515868 D0 GB 9515868D0 GB 9515868 A GB9515868 A GB 9515868A GB 9515868 D0 GB9515868 D0 GB 9515868D0
Authority
GB
United Kingdom
Prior art keywords
therapeutic method
therapeutic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GBGB9515868.9A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Protherics Medicines Development Ltd
Original Assignee
Proteus Molecular Design Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Proteus Molecular Design Ltd filed Critical Proteus Molecular Design Ltd
Priority to GBGB9515868.9A priority Critical patent/GB9515868D0/en
Publication of GB9515868D0 publication Critical patent/GB9515868D0/en
Priority to AU66262/96A priority patent/AU705662B2/en
Priority to JP9507372A priority patent/JPH11510155A/en
Priority to PCT/GB1996/001861 priority patent/WO1997004768A1/en
Priority to EP96925904A priority patent/EP0861074A1/en
Priority to CA002228298A priority patent/CA2228298A1/en
Priority to ZA9606603A priority patent/ZA966603B/en
Priority to MXPA/A/1998/000919A priority patent/MXPA98000919A/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/075—Ethers or acetals
    • A61K31/08—Ethers or acetals acyclic, e.g. paraformaldehyde
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
    • A61K9/1272—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers with substantial amounts of non-phosphatidyl, i.e. non-acylglycerophosphate, surfactants as bilayer-forming substances, e.g. cationic lipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
GBGB9515868.9A 1995-08-02 1995-08-02 Therapeutic method Pending GB9515868D0 (en)

Priority Applications (8)

Application Number Priority Date Filing Date Title
GBGB9515868.9A GB9515868D0 (en) 1995-08-02 1995-08-02 Therapeutic method
AU66262/96A AU705662B2 (en) 1995-08-02 1996-08-01 Non-ionic surfactant vesicles as therapeutic agent
JP9507372A JPH11510155A (en) 1995-08-02 1996-08-01 Method of treatment
PCT/GB1996/001861 WO1997004768A1 (en) 1995-08-02 1996-08-01 Non-ionic surfactant vesicles as therapeutic agent
EP96925904A EP0861074A1 (en) 1995-08-02 1996-08-01 Non-ionic surfactant vesicles as therapeutic agent
CA002228298A CA2228298A1 (en) 1995-08-02 1996-08-01 Non-ionic surfactant vesicles as therapeutic agent
ZA9606603A ZA966603B (en) 1995-08-02 1996-08-02 Therapeutic method.
MXPA/A/1998/000919A MXPA98000919A (en) 1995-08-02 1998-02-02 Non-ionic surfactant vessels as a therapist agent

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9515868.9A GB9515868D0 (en) 1995-08-02 1995-08-02 Therapeutic method

Publications (1)

Publication Number Publication Date
GB9515868D0 true GB9515868D0 (en) 1995-10-04

Family

ID=10778664

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB9515868.9A Pending GB9515868D0 (en) 1995-08-02 1995-08-02 Therapeutic method

Country Status (7)

Country Link
EP (1) EP0861074A1 (en)
JP (1) JPH11510155A (en)
AU (1) AU705662B2 (en)
CA (1) CA2228298A1 (en)
GB (1) GB9515868D0 (en)
WO (1) WO1997004768A1 (en)
ZA (1) ZA966603B (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4676049B2 (en) * 1999-07-21 2011-04-27 生化学工業株式会社 IL-12 production inhibitor
JP4592347B2 (en) * 2003-07-14 2010-12-01 株式会社ヤクルト本社 External preparation composition
DE10358534A1 (en) 2003-12-13 2005-07-14 Henkel Kgaa Adhesion inhibition of microorganisms by nonionic surfactants
US9907746B2 (en) 2009-07-06 2018-03-06 Variation Biotechnologies, Inc. Methods for preparing vesicles and formulations produced therefrom
EP2451950B9 (en) 2009-07-06 2016-11-23 Variation Biotechnologies Inc. Methods for preparing vesicles and formulations produced therefrom
AU2011276223C1 (en) 2010-07-06 2016-05-12 Variation Biotechnologies, Inc. Compositions and methods for treating influenza
MX359103B (en) * 2011-01-13 2018-09-14 Variation Biotechnologies Inc Compositions and methods for treating viral infections.
US20140356399A1 (en) 2012-01-12 2014-12-04 Variation Biotechnologies, Inc. Compositions and methods for treating viral infections
RU2698906C2 (en) * 2012-01-27 2019-09-02 Вэриэйшн Биотекнолоджиз, Инк. Methods and compositions for therapeutic agents
GB201814959D0 (en) 2018-09-14 2018-10-31 Secr Defence Methods for the preparation of a pharmaceutical-vesicle formulation and associated products and uses

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0374333A (en) * 1989-08-11 1991-03-28 Nippon Oil & Fats Co Ltd Reinforcing of carcinostatic property of bleomycin
GB9207731D0 (en) * 1992-04-07 1992-05-27 Proteus Molecular Design Improvements in or relating to vaccines
GB9320597D0 (en) * 1993-10-06 1993-11-24 Proteus Molecular Design Improvements in and realting to vaccines

Also Published As

Publication number Publication date
MX9800919A (en) 1998-10-31
WO1997004768A1 (en) 1997-02-13
ZA966603B (en) 1997-02-18
CA2228298A1 (en) 1997-02-13
AU705662B2 (en) 1999-05-27
EP0861074A1 (en) 1998-09-02
JPH11510155A (en) 1999-09-07
AU6626296A (en) 1997-02-26

Similar Documents

Publication Publication Date Title
IL114162A (en) Submersive therapy apparatus
PL323178A1 (en) Schirophrenia diagnosin method
GB9410320D0 (en) Novel therapeutic method
GB9518442D0 (en) Method
GB9519638D0 (en) Method
GB9515868D0 (en) Therapeutic method
GB2308522B (en) Redialling method
GB9601976D0 (en) Method
GB9510727D0 (en) Method
GB9511828D0 (en) Method
GB9722553D0 (en) Method
GB9520585D0 (en) Therapeutic method
GB9517851D0 (en) New therapeutic method
GB9511927D0 (en) Novel therapeutic method
GB9511354D0 (en) Novel therapeutic method
GB9510671D0 (en) Novel therapeutic method
GB9510663D0 (en) Novel therapeutic method
GB9414242D0 (en) Therapeutic method
GB9410319D0 (en) Novel therapeutic method
GB9411549D0 (en) Novel therapeutic method
GB9410693D0 (en) Novel therapeutic method
GB9410326D0 (en) Novel therapeutic method
GB9513130D0 (en) Treatment method
GB9513129D0 (en) Treatment method
GB9511594D0 (en) Treatment method